The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?

Exp Clin Endocrinol Diabetes. 2023 Jun;131(6):375-376. doi: 10.1055/a-2075-0735. Epub 2023 May 9.

Authors

David M Williams¹, Ayesha Shaikh¹, Ellen Williams², Aiman Maroof², Therese Michael³, Kusuma Boregowda¹

Affiliations

¹ Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL.
² Department of Acute Medicine, Morriston Hospital, Swansea, SA6 6NL.
³ Department of Laboratory Medicine, Morriston Hospital, Swansea, SA6 6NL.

PMID: 37160152
DOI: 10.1055/a-2075-0735

No abstract available

MeSH terms

Aldosterone
Humans
Hyperaldosteronism* / diagnosis
Hyperaldosteronism* / epidemiology
Hypertension* / epidemiology
Hypokalemia* / diagnosis
Hypokalemia* / epidemiology
Hypokalemia* / etiology
Mass Screening
Prevalence

Substances

Aldosterone